News|Articles|June 2, 2020

Approaches to Alleviating Subcutaneous Injection-Site Pain for Citrate Formulations

External Link - PT0620_032-037_PeerReview_Avantor (web watermark).pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Bristol Myers Squibb announced plans to expand its computing infrastructure collaboration with NVIDIA

Everything to Know about BMS & NVidia’s AI Supercomputer

ByZachary Zubulake

July 20th 2026

PharmTech Weekly Roundup—July 17, 2026

BySusan Haigney

July 20th 2026

Brent Wilhelm, Senior Vice President of Global Supply Chain, Cencora

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

ByBrent Wilhelm,Zachary Zubulake

July 20th 2026

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

ByMike Stenberg

July 17th 2026

Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%

ByMegha Sinha,Zachary Zubulake

July 17th 2026

Approaches to Alleviating Subcutaneous Injection-Site Pain for Citrate Formulations

Related Content

Everything to Know about BMS & NVidia’s AI Supercomputer

PharmTech Weekly Roundup—July 17, 2026

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%

Trending on Pharmaceutical Technology

Everything to Know about BMS & NVidia’s AI Supercomputer

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

The Implications of the FDA’s New Finalized Guidance Documents

Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory